GMO TRUST
NSAR-A, EX-27, 2000-10-27
Previous: GMO TRUST, NSAR-A, EX-27, 2000-10-27
Next: GMO TRUST, NSAR-A, EX-27, 2000-10-27



<TABLE> <S> <C>

<ARTICLE> 6
<LEGEND>
This schedule contains summary financial
information extracted from GMO Trust, form
N-SAR for the period ended August 31, 2000
and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<SERIES>
   <NUMBER> 243
   <NAME> GMO Foreign Fund, Class III

<S>                             <C>
<PERIOD-TYPE>                                         6-MOS
<FISCAL-YEAR-END>                               FEB-28-2001
<PERIOD-END>                                    AUG-31-2000
<INVESTMENTS-AT-COST>                        1,085,616,362
<INVESTMENTS-AT-VALUE>                       1,217,810,611
<RECEIVABLES>                                   13,959,069
<ASSETS-OTHER>                                  19,478,854
<OTHER-ITEMS-ASSETS>                                     0
<TOTAL-ASSETS>                               1,251,248,534
<PAYABLE-FOR-SECURITIES>                         3,933,606
<SENIOR-LONG-TERM-DEBT>                                  0
<OTHER-ITEMS-LIABILITIES>                       28,685,403
<TOTAL-LIABILITIES>                             32,619,009
<SENIOR-EQUITY>                                          0
<PAID-IN-CAPITAL-COMMON>                     1,002,617,593
<SHARES-COMMON-STOCK>                           78,430,468
<SHARES-COMMON-PRIOR>                           77,702,492
<ACCUMULATED-NII-CURRENT>                                0
<OVERDISTRIBUTION-NII>                          (6,006,374)
<ACCUMULATED-NET-GAINS>                         90,251,292
<OVERDISTRIBUTION-GAINS>                                 0
<ACCUM-APPREC-OR-DEPREC>                       131,767,014
<NET-ASSETS>                                 1,218,629,525
<DIVIDEND-INCOME>                               17,694,334
<INTEREST-INCOME>                                1,266,610
<OTHER-INCOME>                                           0
<EXPENSES-NET>                                  (4,633,831)
<NET-INVESTMENT-INCOME>                         14,327,113
<REALIZED-GAINS-CURRENT>                        91,782,530
<APPREC-INCREASE-CURRENT>                      (75,631,689)
<NET-CHANGE-FROM-OPS>                           30,477,954
<EQUALIZATION>                                           0
<DISTRIBUTIONS-OF-INCOME>                      (12,121,780)
<DISTRIBUTIONS-OF-GAINS>                       (33,392,072)
<DISTRIBUTIONS-OTHER>                                    0
<NUMBER-OF-SHARES-SOLD>                            976,821
<NUMBER-OF-SHARES-REDEEMED>                     (3,323,349)
<SHARES-REINVESTED>                              3,074,504
<NET-CHANGE-IN-ASSETS>                          (5,322,466)
<ACCUMULATED-NII-PRIOR>                                  0
<ACCUMULATED-GAINS-PRIOR>                       38,633,069
<OVERDISTRIB-NII-PRIOR>                         (5,741,231)
<OVERDIST-NET-GAINS-PRIOR>                               0
<GROSS-ADVISORY-FEES>                            3,710,480
<INTEREST-EXPENSE>                                       0
<GROSS-EXPENSE>                                  5,222,631
<AVERAGE-NET-ASSETS>                         1,226,743,973
<PER-SHARE-NAV-BEGIN>                                13.16
<PER-SHARE-NII>                                       0.15
<PER-SHARE-GAIN-APPREC>                               0.19
<PER-SHARE-DIVIDEND>                                 (0.16)
<PER-SHARE-DISTRIBUTIONS>                            (0.44)
<RETURNS-OF-CAPITAL>                                  0.00
<PER-SHARE-NAV-END>                                  12.90
<EXPENSE-RATIO>                                       0.75


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission